Global Migraine Drugs Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Migraine Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Migraine Drugs Industry Forecast” looks at past sales and reviews total world Migraine Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Migraine Drugs sales for 2025 through 2031. With Migraine Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Migraine Drugs industry.
This Insight Report provides a comprehensive analysis of the global Migraine Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Migraine Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Migraine Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Migraine Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Migraine Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Migraine Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Migraine Drugs market?
What factors are driving Migraine Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Migraine Drugs market opportunities vary by end market size?
How does Migraine Drugs break out by Type, by Application?
The global Migraine Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Migraine Drugs Industry Forecast” looks at past sales and reviews total world Migraine Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Migraine Drugs sales for 2025 through 2031. With Migraine Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Migraine Drugs industry.
This Insight Report provides a comprehensive analysis of the global Migraine Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Migraine Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Migraine Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Migraine Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Migraine Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Migraine Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Sumatriptan
- Zolmitriptan
- Rizatriptan
- Others Drug
- Hospitals
- Clinics
- Household Use
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Allergan
- Merck
- Pfizer
- Teva
- Pfizer
- Johnson & Johnson
- Endo International
- GlaxoSmithKline
- Impax
- Abbott
- Bayer
- Eli Lilly
- Ethypharm
- Kowa Pharmaceuticals America
- Winston Pharmaceuticals
- AstraZeneca
What is the 10-year outlook for the global Migraine Drugs market?
What factors are driving Migraine Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Migraine Drugs market opportunities vary by end market size?
How does Migraine Drugs break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Migraine Drugs Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Migraine Drugs by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Migraine Drugs by Country/Region, 2020, 2024 & 2031
2.2 Migraine Drugs Segment by Type
2.2.1 Sumatriptan
2.2.2 Zolmitriptan
2.2.3 Rizatriptan
2.2.4 Others Drug
2.3 Migraine Drugs Sales by Type
2.3.1 Global Migraine Drugs Sales Market Share by Type (2020-2025)
2.3.2 Global Migraine Drugs Revenue and Market Share by Type (2020-2025)
2.3.3 Global Migraine Drugs Sale Price by Type (2020-2025)
2.4 Migraine Drugs Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Household Use
2.4.4 Others
2.5 Migraine Drugs Sales by Application
2.5.1 Global Migraine Drugs Sale Market Share by Application (2020-2025)
2.5.2 Global Migraine Drugs Revenue and Market Share by Application (2020-2025)
2.5.3 Global Migraine Drugs Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Migraine Drugs Breakdown Data by Company
3.1.1 Global Migraine Drugs Annual Sales by Company (2020-2025)
3.1.2 Global Migraine Drugs Sales Market Share by Company (2020-2025)
3.2 Global Migraine Drugs Annual Revenue by Company (2020-2025)
3.2.1 Global Migraine Drugs Revenue by Company (2020-2025)
3.2.2 Global Migraine Drugs Revenue Market Share by Company (2020-2025)
3.3 Global Migraine Drugs Sale Price by Company
3.4 Key Manufacturers Migraine Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Migraine Drugs Product Location Distribution
3.4.2 Players Migraine Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MIGRAINE DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Migraine Drugs Market Size by Geographic Region (2020-2025)
4.1.1 Global Migraine Drugs Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Migraine Drugs Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Migraine Drugs Market Size by Country/Region (2020-2025)
4.2.1 Global Migraine Drugs Annual Sales by Country/Region (2020-2025)
4.2.2 Global Migraine Drugs Annual Revenue by Country/Region (2020-2025)
4.3 Americas Migraine Drugs Sales Growth
4.4 APAC Migraine Drugs Sales Growth
4.5 Europe Migraine Drugs Sales Growth
4.6 Middle East & Africa Migraine Drugs Sales Growth
5 AMERICAS
5.1 Americas Migraine Drugs Sales by Country
5.1.1 Americas Migraine Drugs Sales by Country (2020-2025)
5.1.2 Americas Migraine Drugs Revenue by Country (2020-2025)
5.2 Americas Migraine Drugs Sales by Type (2020-2025)
5.3 Americas Migraine Drugs Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Migraine Drugs Sales by Region
6.1.1 APAC Migraine Drugs Sales by Region (2020-2025)
6.1.2 APAC Migraine Drugs Revenue by Region (2020-2025)
6.2 APAC Migraine Drugs Sales by Type (2020-2025)
6.3 APAC Migraine Drugs Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Migraine Drugs by Country
7.1.1 Europe Migraine Drugs Sales by Country (2020-2025)
7.1.2 Europe Migraine Drugs Revenue by Country (2020-2025)
7.2 Europe Migraine Drugs Sales by Type (2020-2025)
7.3 Europe Migraine Drugs Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Migraine Drugs by Country
8.1.1 Middle East & Africa Migraine Drugs Sales by Country (2020-2025)
8.1.2 Middle East & Africa Migraine Drugs Revenue by Country (2020-2025)
8.2 Middle East & Africa Migraine Drugs Sales by Type (2020-2025)
8.3 Middle East & Africa Migraine Drugs Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Migraine Drugs
10.3 Manufacturing Process Analysis of Migraine Drugs
10.4 Industry Chain Structure of Migraine Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Migraine Drugs Distributors
11.3 Migraine Drugs Customer
12 WORLD FORECAST REVIEW FOR MIGRAINE DRUGS BY GEOGRAPHIC REGION
12.1 Global Migraine Drugs Market Size Forecast by Region
12.1.1 Global Migraine Drugs Forecast by Region (2026-2031)
12.1.2 Global Migraine Drugs Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Migraine Drugs Forecast by Type (2026-2031)
12.7 Global Migraine Drugs Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Allergan
13.1.1 Allergan Company Information
13.1.2 Allergan Migraine Drugs Product Portfolios and Specifications
13.1.3 Allergan Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Allergan Main Business Overview
13.1.5 Allergan Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Migraine Drugs Product Portfolios and Specifications
13.2.3 Merck Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer Migraine Drugs Product Portfolios and Specifications
13.3.3 Pfizer Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 Teva
13.4.1 Teva Company Information
13.4.2 Teva Migraine Drugs Product Portfolios and Specifications
13.4.3 Teva Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Teva Main Business Overview
13.4.5 Teva Latest Developments
13.5 Pfizer
13.5.1 Pfizer Company Information
13.5.2 Pfizer Migraine Drugs Product Portfolios and Specifications
13.5.3 Pfizer Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Pfizer Main Business Overview
13.5.5 Pfizer Latest Developments
13.6 Johnson & Johnson
13.6.1 Johnson & Johnson Company Information
13.6.2 Johnson & Johnson Migraine Drugs Product Portfolios and Specifications
13.6.3 Johnson & Johnson Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Johnson & Johnson Main Business Overview
13.6.5 Johnson & Johnson Latest Developments
13.7 Endo International
13.7.1 Endo International Company Information
13.7.2 Endo International Migraine Drugs Product Portfolios and Specifications
13.7.3 Endo International Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Endo International Main Business Overview
13.7.5 Endo International Latest Developments
13.8 GlaxoSmithKline
13.8.1 GlaxoSmithKline Company Information
13.8.2 GlaxoSmithKline Migraine Drugs Product Portfolios and Specifications
13.8.3 GlaxoSmithKline Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 GlaxoSmithKline Main Business Overview
13.8.5 GlaxoSmithKline Latest Developments
13.9 Impax
13.9.1 Impax Company Information
13.9.2 Impax Migraine Drugs Product Portfolios and Specifications
13.9.3 Impax Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Impax Main Business Overview
13.9.5 Impax Latest Developments
13.10 Abbott
13.10.1 Abbott Company Information
13.10.2 Abbott Migraine Drugs Product Portfolios and Specifications
13.10.3 Abbott Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Abbott Main Business Overview
13.10.5 Abbott Latest Developments
13.11 Bayer
13.11.1 Bayer Company Information
13.11.2 Bayer Migraine Drugs Product Portfolios and Specifications
13.11.3 Bayer Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Bayer Main Business Overview
13.11.5 Bayer Latest Developments
13.12 Eli Lilly
13.12.1 Eli Lilly Company Information
13.12.2 Eli Lilly Migraine Drugs Product Portfolios and Specifications
13.12.3 Eli Lilly Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Eli Lilly Main Business Overview
13.12.5 Eli Lilly Latest Developments
13.13 Ethypharm
13.13.1 Ethypharm Company Information
13.13.2 Ethypharm Migraine Drugs Product Portfolios and Specifications
13.13.3 Ethypharm Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Ethypharm Main Business Overview
13.13.5 Ethypharm Latest Developments
13.14 Kowa Pharmaceuticals America
13.14.1 Kowa Pharmaceuticals America Company Information
13.14.2 Kowa Pharmaceuticals America Migraine Drugs Product Portfolios and Specifications
13.14.3 Kowa Pharmaceuticals America Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Kowa Pharmaceuticals America Main Business Overview
13.14.5 Kowa Pharmaceuticals America Latest Developments
13.15 Winston Pharmaceuticals
13.15.1 Winston Pharmaceuticals Company Information
13.15.2 Winston Pharmaceuticals Migraine Drugs Product Portfolios and Specifications
13.15.3 Winston Pharmaceuticals Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Winston Pharmaceuticals Main Business Overview
13.15.5 Winston Pharmaceuticals Latest Developments
13.16 AstraZeneca
13.16.1 AstraZeneca Company Information
13.16.2 AstraZeneca Migraine Drugs Product Portfolios and Specifications
13.16.3 AstraZeneca Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 AstraZeneca Main Business Overview
13.16.5 AstraZeneca Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Migraine Drugs Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Migraine Drugs Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Sumatriptan
Table 4. Major Players of Zolmitriptan
Table 5. Major Players of Rizatriptan
Table 6. Major Players of Others Drug
Table 7. Global Migraine Drugs Sales byType (2020-2025) & (K Pcs)
Table 8. Global Migraine Drugs Sales Market Share byType (2020-2025)
Table 9. Global Migraine Drugs Revenue byType (2020-2025) & ($ million)
Table 10. Global Migraine Drugs Revenue Market Share byType (2020-2025)
Table 11. Global Migraine Drugs Sale Price byType (2020-2025) & (USD/Pcs)
Table 12. Global Migraine Drugs Sale by Application (2020-2025) & (K Pcs)
Table 13. Global Migraine Drugs Sale Market Share by Application (2020-2025)
Table 14. Global Migraine Drugs Revenue by Application (2020-2025) & ($ million)
Table 15. Global Migraine Drugs Revenue Market Share by Application (2020-2025)
Table 16. Global Migraine Drugs Sale Price by Application (2020-2025) & (USD/Pcs)
Table 17. Global Migraine Drugs Sales by Company (2020-2025) & (K Pcs)
Table 18. Global Migraine Drugs Sales Market Share by Company (2020-2025)
Table 19. Global Migraine Drugs Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Migraine Drugs Revenue Market Share by Company (2020-2025)
Table 21. Global Migraine Drugs Sale Price by Company (2020-2025) & (USD/Pcs)
Table 22. Key Manufacturers Migraine Drugs Producing Area Distribution and Sales Area
Table 23. Players Migraine Drugs Products Offered
Table 24. Migraine Drugs Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Migraine Drugs Sales by Geographic Region (2020-2025) & (K Pcs)
Table 28. Global Migraine Drugs Sales Market Share Geographic Region (2020-2025)
Table 29. Global Migraine Drugs Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Migraine Drugs Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Migraine Drugs Sales by Country/Region (2020-2025) & (K Pcs)
Table 32. Global Migraine Drugs Sales Market Share by Country/Region (2020-2025)
Table 33. Global Migraine Drugs Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Migraine Drugs Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Migraine Drugs Sales by Country (2020-2025) & (K Pcs)
Table 36. Americas Migraine Drugs Sales Market Share by Country (2020-2025)
Table 37. Americas Migraine Drugs Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Migraine Drugs Sales byType (2020-2025) & (K Pcs)
Table 39. Americas Migraine Drugs Sales by Application (2020-2025) & (K Pcs)
Table 40. APAC Migraine Drugs Sales by Region (2020-2025) & (K Pcs)
Table 41. APAC Migraine Drugs Sales Market Share by Region (2020-2025)
Table 42. APAC Migraine Drugs Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Migraine Drugs Sales byType (2020-2025) & (K Pcs)
Table 44. APAC Migraine Drugs Sales by Application (2020-2025) & (K Pcs)
Table 45. Europe Migraine Drugs Sales by Country (2020-2025) & (K Pcs)
Table 46. Europe Migraine Drugs Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Migraine Drugs Sales byType (2020-2025) & (K Pcs)
Table 48. Europe Migraine Drugs Sales by Application (2020-2025) & (K Pcs)
Table 49. Middle East & Africa Migraine Drugs Sales by Country (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Migraine Drugs Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Migraine Drugs Sales byType (2020-2025) & (K Pcs)
Table 52. Middle East & Africa Migraine Drugs Sales by Application (2020-2025) & (K Pcs)
Table 53. Key Market Drivers & Growth Opportunities of Migraine Drugs
Table 54. Key Market Challenges & Risks of Migraine Drugs
Table 55. Key IndustryTrends of Migraine Drugs
Table 56. Migraine Drugs Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Migraine Drugs Distributors List
Table 59. Migraine Drugs Customer List
Table 60. Global Migraine Drugs SalesForecast by Region (2026-2031) & (K Pcs)
Table 61. Global Migraine Drugs RevenueForecast by Region (2026-2031) & ($ millions)
Table 62. Americas Migraine Drugs SalesForecast by Country (2026-2031) & (K Pcs)
Table 63. Americas Migraine Drugs Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 64. APAC Migraine Drugs SalesForecast by Region (2026-2031) & (K Pcs)
Table 65. APAC Migraine Drugs Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 66. Europe Migraine Drugs SalesForecast by Country (2026-2031) & (K Pcs)
Table 67. Europe Migraine Drugs RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Migraine Drugs SalesForecast by Country (2026-2031) & (K Pcs)
Table 69. Middle East & Africa Migraine Drugs RevenueForecast by Country (2026-2031) & ($ millions)
Table 70. Global Migraine Drugs SalesForecast byType (2026-2031) & (K Pcs)
Table 71. Global Migraine Drugs RevenueForecast byType (2026-2031) & ($ millions)
Table 72. Global Migraine Drugs SalesForecast by Application (2026-2031) & (K Pcs)
Table 73. Global Migraine Drugs RevenueForecast by Application (2026-2031) & ($ millions)
Table 74. Allergan Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
Table 75. Allergan Migraine Drugs Product Portfolios and Specifications
Table 76. Allergan Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 77. Allergan Main Business
Table 78. Allergan Latest Developments
Table 79. Merck Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
Table 80. Merck Migraine Drugs Product Portfolios and Specifications
Table 81. Merck Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 82. Merck Main Business
Table 83. Merck Latest Developments
Table 84. Pfizer Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
Table 85. Pfizer Migraine Drugs Product Portfolios and Specifications
Table 86. Pfizer Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 87. Pfizer Main Business
Table 88. Pfizer Latest Developments
Table 89.Teva Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
Table 90.Teva Migraine Drugs Product Portfolios and Specifications
Table 91.Teva Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 92.Teva Main Business
Table 93.Teva Latest Developments
Table 94. Pfizer Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Pfizer Migraine Drugs Product Portfolios and Specifications
Table 96. Pfizer Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 97. Pfizer Main Business
Table 98. Pfizer Latest Developments
Table 99. Johnson & Johnson Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. Johnson & Johnson Migraine Drugs Product Portfolios and Specifications
Table 101. Johnson & Johnson Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 102. Johnson & Johnson Main Business
Table 103. Johnson & Johnson Latest Developments
Table 104. Endo International Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
Table 105. Endo International Migraine Drugs Product Portfolios and Specifications
Table 106. Endo International Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 107. Endo International Main Business
Table 108. Endo International Latest Developments
Table 109. GlaxoSmithKline Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
Table 110. GlaxoSmithKline Migraine Drugs Product Portfolios and Specifications
Table 111. GlaxoSmithKline Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 112. GlaxoSmithKline Main Business
Table 113. GlaxoSmithKline Latest Developments
Table 114. Impax Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
Table 115. Impax Migraine Drugs Product Portfolios and Specifications
Table 116. Impax Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 117. Impax Main Business
Table 118. Impax Latest Developments
Table 119. Abbott Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
Table 120. Abbott Migraine Drugs Product Portfolios and Specifications
Table 121. Abbott Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 122. Abbott Main Business
Table 123. Abbott Latest Developments
Table 124. Bayer Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
Table 125. Bayer Migraine Drugs Product Portfolios and Specifications
Table 126. Bayer Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 127. Bayer Main Business
Table 128. Bayer Latest Developments
Table 129. Eli Lilly Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
Table 130. Eli Lilly Migraine Drugs Product Portfolios and Specifications
Table 131. Eli Lilly Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 132. Eli Lilly Main Business
Table 133. Eli Lilly Latest Developments
Table 134. Ethypharm Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
Table 135. Ethypharm Migraine Drugs Product Portfolios and Specifications
Table 136. Ethypharm Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 137. Ethypharm Main Business
Table 138. Ethypharm Latest Developments
Table 139. Kowa Pharmaceuticals America Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
Table 140. Kowa Pharmaceuticals America Migraine Drugs Product Portfolios and Specifications
Table 141. Kowa Pharmaceuticals America Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 142. Kowa Pharmaceuticals America Main Business
Table 143. Kowa Pharmaceuticals America Latest Developments
Table 144. Winston Pharmaceuticals Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
Table 145. Winston Pharmaceuticals Migraine Drugs Product Portfolios and Specifications
Table 146. Winston Pharmaceuticals Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 147. Winston Pharmaceuticals Main Business
Table 148. Winston Pharmaceuticals Latest Developments
Table 149. AstraZeneca Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
Table 150. AstraZeneca Migraine Drugs Product Portfolios and Specifications
Table 151. AstraZeneca Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 152. AstraZeneca Main Business
Table 153. AstraZeneca Latest Developments
LIST OFFIGURES
Figure 1. Picture of Migraine Drugs
Figure 2. Migraine Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Migraine Drugs Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Migraine Drugs Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Migraine Drugs Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Migraine Drugs Sales Market Share by Country/Region (2024)
Figure 10. Migraine Drugs Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Sumatriptan
Figure 12. Product Picture of Zolmitriptan
Figure 13. Product Picture of Rizatriptan
Figure 14. Product Picture of Others Drug
Figure 15. Global Migraine Drugs Sales Market Share byType in 2025
Figure 16. Global Migraine Drugs Revenue Market Share byType (2020-2025)
Figure 17. Migraine Drugs Consumed in Hospitals
Figure 18. Global Migraine Drugs Market: Hospitals (2020-2025) & (K Pcs)
Figure 19. Migraine Drugs Consumed in Clinics
Figure 20. Global Migraine Drugs Market: Clinics (2020-2025) & (K Pcs)
Figure 21. Migraine Drugs Consumed in Household Use
Figure 22. Global Migraine Drugs Market: Household Use (2020-2025) & (K Pcs)
Figure 23. Migraine Drugs Consumed in Others
Figure 24. Global Migraine Drugs Market: Others (2020-2025) & (K Pcs)
Figure 25. Global Migraine Drugs Sale Market Share by Application (2024)
Figure 26. Global Migraine Drugs Revenue Market Share by Application in 2025
Figure 27. Migraine Drugs Sales by Company in 2025 (K Pcs)
Figure 28. Global Migraine Drugs Sales Market Share by Company in 2025
Figure 29. Migraine Drugs Revenue by Company in 2025 ($ millions)
Figure 30. Global Migraine Drugs Revenue Market Share by Company in 2025
Figure 31. Global Migraine Drugs Sales Market Share by Geographic Region (2020-2025)
Figure 32. Global Migraine Drugs Revenue Market Share by Geographic Region in 2025
Figure 33. Americas Migraine Drugs Sales 2020-2025 (K Pcs)
Figure 34. Americas Migraine Drugs Revenue 2020-2025 ($ millions)
Figure 35. APAC Migraine Drugs Sales 2020-2025 (K Pcs)
Figure 36. APAC Migraine Drugs Revenue 2020-2025 ($ millions)
Figure 37. Europe Migraine Drugs Sales 2020-2025 (K Pcs)
Figure 38. Europe Migraine Drugs Revenue 2020-2025 ($ millions)
Figure 39. Middle East & Africa Migraine Drugs Sales 2020-2025 (K Pcs)
Figure 40. Middle East & Africa Migraine Drugs Revenue 2020-2025 ($ millions)
Figure 41. Americas Migraine Drugs Sales Market Share by Country in 2025
Figure 42. Americas Migraine Drugs Revenue Market Share by Country (2020-2025)
Figure 43. Americas Migraine Drugs Sales Market Share byType (2020-2025)
Figure 44. Americas Migraine Drugs Sales Market Share by Application (2020-2025)
Figure 45. United States Migraine Drugs Revenue Growth 2020-2025 ($ millions)
Figure 46. Canada Migraine Drugs Revenue Growth 2020-2025 ($ millions)
Figure 47. Mexico Migraine Drugs Revenue Growth 2020-2025 ($ millions)
Figure 48. Brazil Migraine Drugs Revenue Growth 2020-2025 ($ millions)
Figure 49. APAC Migraine Drugs Sales Market Share by Region in 2025
Figure 50. APAC Migraine Drugs Revenue Market Share by Region (2020-2025)
Figure 51. APAC Migraine Drugs Sales Market Share byType (2020-2025)
Figure 52. APAC Migraine Drugs Sales Market Share by Application (2020-2025)
Figure 53. China Migraine Drugs Revenue Growth 2020-2025 ($ millions)
Figure 54. Japan Migraine Drugs Revenue Growth 2020-2025 ($ millions)
Figure 55. South Korea Migraine Drugs Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast Asia Migraine Drugs Revenue Growth 2020-2025 ($ millions)
Figure 57. India Migraine Drugs Revenue Growth 2020-2025 ($ millions)
Figure 58. Australia Migraine Drugs Revenue Growth 2020-2025 ($ millions)
Figure 59. ChinaTaiwan Migraine Drugs Revenue Growth 2020-2025 ($ millions)
Figure 60. Europe Migraine Drugs Sales Market Share by Country in 2025
Figure 61. Europe Migraine Drugs Revenue Market Share by Country (2020-2025)
Figure 62. Europe Migraine Drugs Sales Market Share byType (2020-2025)
Figure 63. Europe Migraine Drugs Sales Market Share by Application (2020-2025)
Figure 64. Germany Migraine Drugs Revenue Growth 2020-2025 ($ millions)
Figure 65.France Migraine Drugs Revenue Growth 2020-2025 ($ millions)
Figure 66. UK Migraine Drugs Revenue Growth 2020-2025 ($ millions)
Figure 67. Italy Migraine Drugs Revenue Growth 2020-2025 ($ millions)
Figure 68. Russia Migraine Drugs Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & Africa Migraine Drugs Sales Market Share by Country (2020-2025)
Figure 70. Middle East & Africa Migraine Drugs Sales Market Share byType (2020-2025)
Figure 71. Middle East & Africa Migraine Drugs Sales Market Share by Application (2020-2025)
Figure 72. Egypt Migraine Drugs Revenue Growth 2020-2025 ($ millions)
Figure 73. South Africa Migraine Drugs Revenue Growth 2020-2025 ($ millions)
Figure 74. Israel Migraine Drugs Revenue Growth 2020-2025 ($ millions)
Figure 75.Turkey Migraine Drugs Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC Countries Migraine Drugs Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Migraine Drugs in 2025
Figure 78. Manufacturing Process Analysis of Migraine Drugs
Figure 79. Industry Chain Structure of Migraine Drugs
Figure 80. Channels of Distribution
Figure 81. Global Migraine Drugs Sales MarketForecast by Region (2026-2031)
Figure 82. Global Migraine Drugs Revenue Market ShareForecast by Region (2026-2031)
Figure 83. Global Migraine Drugs Sales Market ShareForecast byType (2026-2031)
Figure 84. Global Migraine Drugs Revenue Market ShareForecast byType (2026-2031)
Figure 85. Global Migraine Drugs Sales Market ShareForecast by Application (2026-2031)
Figure 86. Global Migraine Drugs Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Migraine Drugs Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Migraine Drugs by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Migraine Drugs by Country/Region, 2020, 2024 & 2031
2.2 Migraine Drugs Segment by Type
2.2.1 Sumatriptan
2.2.2 Zolmitriptan
2.2.3 Rizatriptan
2.2.4 Others Drug
2.3 Migraine Drugs Sales by Type
2.3.1 Global Migraine Drugs Sales Market Share by Type (2020-2025)
2.3.2 Global Migraine Drugs Revenue and Market Share by Type (2020-2025)
2.3.3 Global Migraine Drugs Sale Price by Type (2020-2025)
2.4 Migraine Drugs Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Household Use
2.4.4 Others
2.5 Migraine Drugs Sales by Application
2.5.1 Global Migraine Drugs Sale Market Share by Application (2020-2025)
2.5.2 Global Migraine Drugs Revenue and Market Share by Application (2020-2025)
2.5.3 Global Migraine Drugs Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Migraine Drugs Breakdown Data by Company
3.1.1 Global Migraine Drugs Annual Sales by Company (2020-2025)
3.1.2 Global Migraine Drugs Sales Market Share by Company (2020-2025)
3.2 Global Migraine Drugs Annual Revenue by Company (2020-2025)
3.2.1 Global Migraine Drugs Revenue by Company (2020-2025)
3.2.2 Global Migraine Drugs Revenue Market Share by Company (2020-2025)
3.3 Global Migraine Drugs Sale Price by Company
3.4 Key Manufacturers Migraine Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Migraine Drugs Product Location Distribution
3.4.2 Players Migraine Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MIGRAINE DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Migraine Drugs Market Size by Geographic Region (2020-2025)
4.1.1 Global Migraine Drugs Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Migraine Drugs Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Migraine Drugs Market Size by Country/Region (2020-2025)
4.2.1 Global Migraine Drugs Annual Sales by Country/Region (2020-2025)
4.2.2 Global Migraine Drugs Annual Revenue by Country/Region (2020-2025)
4.3 Americas Migraine Drugs Sales Growth
4.4 APAC Migraine Drugs Sales Growth
4.5 Europe Migraine Drugs Sales Growth
4.6 Middle East & Africa Migraine Drugs Sales Growth
5 AMERICAS
5.1 Americas Migraine Drugs Sales by Country
5.1.1 Americas Migraine Drugs Sales by Country (2020-2025)
5.1.2 Americas Migraine Drugs Revenue by Country (2020-2025)
5.2 Americas Migraine Drugs Sales by Type (2020-2025)
5.3 Americas Migraine Drugs Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Migraine Drugs Sales by Region
6.1.1 APAC Migraine Drugs Sales by Region (2020-2025)
6.1.2 APAC Migraine Drugs Revenue by Region (2020-2025)
6.2 APAC Migraine Drugs Sales by Type (2020-2025)
6.3 APAC Migraine Drugs Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Migraine Drugs by Country
7.1.1 Europe Migraine Drugs Sales by Country (2020-2025)
7.1.2 Europe Migraine Drugs Revenue by Country (2020-2025)
7.2 Europe Migraine Drugs Sales by Type (2020-2025)
7.3 Europe Migraine Drugs Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Migraine Drugs by Country
8.1.1 Middle East & Africa Migraine Drugs Sales by Country (2020-2025)
8.1.2 Middle East & Africa Migraine Drugs Revenue by Country (2020-2025)
8.2 Middle East & Africa Migraine Drugs Sales by Type (2020-2025)
8.3 Middle East & Africa Migraine Drugs Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Migraine Drugs
10.3 Manufacturing Process Analysis of Migraine Drugs
10.4 Industry Chain Structure of Migraine Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Migraine Drugs Distributors
11.3 Migraine Drugs Customer
12 WORLD FORECAST REVIEW FOR MIGRAINE DRUGS BY GEOGRAPHIC REGION
12.1 Global Migraine Drugs Market Size Forecast by Region
12.1.1 Global Migraine Drugs Forecast by Region (2026-2031)
12.1.2 Global Migraine Drugs Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Migraine Drugs Forecast by Type (2026-2031)
12.7 Global Migraine Drugs Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Allergan
13.1.1 Allergan Company Information
13.1.2 Allergan Migraine Drugs Product Portfolios and Specifications
13.1.3 Allergan Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Allergan Main Business Overview
13.1.5 Allergan Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Migraine Drugs Product Portfolios and Specifications
13.2.3 Merck Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer Migraine Drugs Product Portfolios and Specifications
13.3.3 Pfizer Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 Teva
13.4.1 Teva Company Information
13.4.2 Teva Migraine Drugs Product Portfolios and Specifications
13.4.3 Teva Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Teva Main Business Overview
13.4.5 Teva Latest Developments
13.5 Pfizer
13.5.1 Pfizer Company Information
13.5.2 Pfizer Migraine Drugs Product Portfolios and Specifications
13.5.3 Pfizer Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Pfizer Main Business Overview
13.5.5 Pfizer Latest Developments
13.6 Johnson & Johnson
13.6.1 Johnson & Johnson Company Information
13.6.2 Johnson & Johnson Migraine Drugs Product Portfolios and Specifications
13.6.3 Johnson & Johnson Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Johnson & Johnson Main Business Overview
13.6.5 Johnson & Johnson Latest Developments
13.7 Endo International
13.7.1 Endo International Company Information
13.7.2 Endo International Migraine Drugs Product Portfolios and Specifications
13.7.3 Endo International Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Endo International Main Business Overview
13.7.5 Endo International Latest Developments
13.8 GlaxoSmithKline
13.8.1 GlaxoSmithKline Company Information
13.8.2 GlaxoSmithKline Migraine Drugs Product Portfolios and Specifications
13.8.3 GlaxoSmithKline Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 GlaxoSmithKline Main Business Overview
13.8.5 GlaxoSmithKline Latest Developments
13.9 Impax
13.9.1 Impax Company Information
13.9.2 Impax Migraine Drugs Product Portfolios and Specifications
13.9.3 Impax Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Impax Main Business Overview
13.9.5 Impax Latest Developments
13.10 Abbott
13.10.1 Abbott Company Information
13.10.2 Abbott Migraine Drugs Product Portfolios and Specifications
13.10.3 Abbott Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Abbott Main Business Overview
13.10.5 Abbott Latest Developments
13.11 Bayer
13.11.1 Bayer Company Information
13.11.2 Bayer Migraine Drugs Product Portfolios and Specifications
13.11.3 Bayer Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Bayer Main Business Overview
13.11.5 Bayer Latest Developments
13.12 Eli Lilly
13.12.1 Eli Lilly Company Information
13.12.2 Eli Lilly Migraine Drugs Product Portfolios and Specifications
13.12.3 Eli Lilly Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Eli Lilly Main Business Overview
13.12.5 Eli Lilly Latest Developments
13.13 Ethypharm
13.13.1 Ethypharm Company Information
13.13.2 Ethypharm Migraine Drugs Product Portfolios and Specifications
13.13.3 Ethypharm Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Ethypharm Main Business Overview
13.13.5 Ethypharm Latest Developments
13.14 Kowa Pharmaceuticals America
13.14.1 Kowa Pharmaceuticals America Company Information
13.14.2 Kowa Pharmaceuticals America Migraine Drugs Product Portfolios and Specifications
13.14.3 Kowa Pharmaceuticals America Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Kowa Pharmaceuticals America Main Business Overview
13.14.5 Kowa Pharmaceuticals America Latest Developments
13.15 Winston Pharmaceuticals
13.15.1 Winston Pharmaceuticals Company Information
13.15.2 Winston Pharmaceuticals Migraine Drugs Product Portfolios and Specifications
13.15.3 Winston Pharmaceuticals Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Winston Pharmaceuticals Main Business Overview
13.15.5 Winston Pharmaceuticals Latest Developments
13.16 AstraZeneca
13.16.1 AstraZeneca Company Information
13.16.2 AstraZeneca Migraine Drugs Product Portfolios and Specifications
13.16.3 AstraZeneca Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 AstraZeneca Main Business Overview
13.16.5 AstraZeneca Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Migraine Drugs Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Migraine Drugs Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Sumatriptan
Table 4. Major Players of Zolmitriptan
Table 5. Major Players of Rizatriptan
Table 6. Major Players of Others Drug
Table 7. Global Migraine Drugs Sales byType (2020-2025) & (K Pcs)
Table 8. Global Migraine Drugs Sales Market Share byType (2020-2025)
Table 9. Global Migraine Drugs Revenue byType (2020-2025) & ($ million)
Table 10. Global Migraine Drugs Revenue Market Share byType (2020-2025)
Table 11. Global Migraine Drugs Sale Price byType (2020-2025) & (USD/Pcs)
Table 12. Global Migraine Drugs Sale by Application (2020-2025) & (K Pcs)
Table 13. Global Migraine Drugs Sale Market Share by Application (2020-2025)
Table 14. Global Migraine Drugs Revenue by Application (2020-2025) & ($ million)
Table 15. Global Migraine Drugs Revenue Market Share by Application (2020-2025)
Table 16. Global Migraine Drugs Sale Price by Application (2020-2025) & (USD/Pcs)
Table 17. Global Migraine Drugs Sales by Company (2020-2025) & (K Pcs)
Table 18. Global Migraine Drugs Sales Market Share by Company (2020-2025)
Table 19. Global Migraine Drugs Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Migraine Drugs Revenue Market Share by Company (2020-2025)
Table 21. Global Migraine Drugs Sale Price by Company (2020-2025) & (USD/Pcs)
Table 22. Key Manufacturers Migraine Drugs Producing Area Distribution and Sales Area
Table 23. Players Migraine Drugs Products Offered
Table 24. Migraine Drugs Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Migraine Drugs Sales by Geographic Region (2020-2025) & (K Pcs)
Table 28. Global Migraine Drugs Sales Market Share Geographic Region (2020-2025)
Table 29. Global Migraine Drugs Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Migraine Drugs Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Migraine Drugs Sales by Country/Region (2020-2025) & (K Pcs)
Table 32. Global Migraine Drugs Sales Market Share by Country/Region (2020-2025)
Table 33. Global Migraine Drugs Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Migraine Drugs Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Migraine Drugs Sales by Country (2020-2025) & (K Pcs)
Table 36. Americas Migraine Drugs Sales Market Share by Country (2020-2025)
Table 37. Americas Migraine Drugs Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Migraine Drugs Sales byType (2020-2025) & (K Pcs)
Table 39. Americas Migraine Drugs Sales by Application (2020-2025) & (K Pcs)
Table 40. APAC Migraine Drugs Sales by Region (2020-2025) & (K Pcs)
Table 41. APAC Migraine Drugs Sales Market Share by Region (2020-2025)
Table 42. APAC Migraine Drugs Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Migraine Drugs Sales byType (2020-2025) & (K Pcs)
Table 44. APAC Migraine Drugs Sales by Application (2020-2025) & (K Pcs)
Table 45. Europe Migraine Drugs Sales by Country (2020-2025) & (K Pcs)
Table 46. Europe Migraine Drugs Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Migraine Drugs Sales byType (2020-2025) & (K Pcs)
Table 48. Europe Migraine Drugs Sales by Application (2020-2025) & (K Pcs)
Table 49. Middle East & Africa Migraine Drugs Sales by Country (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Migraine Drugs Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Migraine Drugs Sales byType (2020-2025) & (K Pcs)
Table 52. Middle East & Africa Migraine Drugs Sales by Application (2020-2025) & (K Pcs)
Table 53. Key Market Drivers & Growth Opportunities of Migraine Drugs
Table 54. Key Market Challenges & Risks of Migraine Drugs
Table 55. Key IndustryTrends of Migraine Drugs
Table 56. Migraine Drugs Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Migraine Drugs Distributors List
Table 59. Migraine Drugs Customer List
Table 60. Global Migraine Drugs SalesForecast by Region (2026-2031) & (K Pcs)
Table 61. Global Migraine Drugs RevenueForecast by Region (2026-2031) & ($ millions)
Table 62. Americas Migraine Drugs SalesForecast by Country (2026-2031) & (K Pcs)
Table 63. Americas Migraine Drugs Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 64. APAC Migraine Drugs SalesForecast by Region (2026-2031) & (K Pcs)
Table 65. APAC Migraine Drugs Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 66. Europe Migraine Drugs SalesForecast by Country (2026-2031) & (K Pcs)
Table 67. Europe Migraine Drugs RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Migraine Drugs SalesForecast by Country (2026-2031) & (K Pcs)
Table 69. Middle East & Africa Migraine Drugs RevenueForecast by Country (2026-2031) & ($ millions)
Table 70. Global Migraine Drugs SalesForecast byType (2026-2031) & (K Pcs)
Table 71. Global Migraine Drugs RevenueForecast byType (2026-2031) & ($ millions)
Table 72. Global Migraine Drugs SalesForecast by Application (2026-2031) & (K Pcs)
Table 73. Global Migraine Drugs RevenueForecast by Application (2026-2031) & ($ millions)
Table 74. Allergan Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
Table 75. Allergan Migraine Drugs Product Portfolios and Specifications
Table 76. Allergan Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 77. Allergan Main Business
Table 78. Allergan Latest Developments
Table 79. Merck Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
Table 80. Merck Migraine Drugs Product Portfolios and Specifications
Table 81. Merck Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 82. Merck Main Business
Table 83. Merck Latest Developments
Table 84. Pfizer Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
Table 85. Pfizer Migraine Drugs Product Portfolios and Specifications
Table 86. Pfizer Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 87. Pfizer Main Business
Table 88. Pfizer Latest Developments
Table 89.Teva Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
Table 90.Teva Migraine Drugs Product Portfolios and Specifications
Table 91.Teva Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 92.Teva Main Business
Table 93.Teva Latest Developments
Table 94. Pfizer Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Pfizer Migraine Drugs Product Portfolios and Specifications
Table 96. Pfizer Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 97. Pfizer Main Business
Table 98. Pfizer Latest Developments
Table 99. Johnson & Johnson Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. Johnson & Johnson Migraine Drugs Product Portfolios and Specifications
Table 101. Johnson & Johnson Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 102. Johnson & Johnson Main Business
Table 103. Johnson & Johnson Latest Developments
Table 104. Endo International Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
Table 105. Endo International Migraine Drugs Product Portfolios and Specifications
Table 106. Endo International Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 107. Endo International Main Business
Table 108. Endo International Latest Developments
Table 109. GlaxoSmithKline Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
Table 110. GlaxoSmithKline Migraine Drugs Product Portfolios and Specifications
Table 111. GlaxoSmithKline Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 112. GlaxoSmithKline Main Business
Table 113. GlaxoSmithKline Latest Developments
Table 114. Impax Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
Table 115. Impax Migraine Drugs Product Portfolios and Specifications
Table 116. Impax Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 117. Impax Main Business
Table 118. Impax Latest Developments
Table 119. Abbott Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
Table 120. Abbott Migraine Drugs Product Portfolios and Specifications
Table 121. Abbott Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 122. Abbott Main Business
Table 123. Abbott Latest Developments
Table 124. Bayer Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
Table 125. Bayer Migraine Drugs Product Portfolios and Specifications
Table 126. Bayer Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 127. Bayer Main Business
Table 128. Bayer Latest Developments
Table 129. Eli Lilly Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
Table 130. Eli Lilly Migraine Drugs Product Portfolios and Specifications
Table 131. Eli Lilly Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 132. Eli Lilly Main Business
Table 133. Eli Lilly Latest Developments
Table 134. Ethypharm Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
Table 135. Ethypharm Migraine Drugs Product Portfolios and Specifications
Table 136. Ethypharm Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 137. Ethypharm Main Business
Table 138. Ethypharm Latest Developments
Table 139. Kowa Pharmaceuticals America Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
Table 140. Kowa Pharmaceuticals America Migraine Drugs Product Portfolios and Specifications
Table 141. Kowa Pharmaceuticals America Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 142. Kowa Pharmaceuticals America Main Business
Table 143. Kowa Pharmaceuticals America Latest Developments
Table 144. Winston Pharmaceuticals Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
Table 145. Winston Pharmaceuticals Migraine Drugs Product Portfolios and Specifications
Table 146. Winston Pharmaceuticals Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 147. Winston Pharmaceuticals Main Business
Table 148. Winston Pharmaceuticals Latest Developments
Table 149. AstraZeneca Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
Table 150. AstraZeneca Migraine Drugs Product Portfolios and Specifications
Table 151. AstraZeneca Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 152. AstraZeneca Main Business
Table 153. AstraZeneca Latest Developments
LIST OFFIGURES
Figure 1. Picture of Migraine Drugs
Figure 2. Migraine Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Migraine Drugs Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Migraine Drugs Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Migraine Drugs Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Migraine Drugs Sales Market Share by Country/Region (2024)
Figure 10. Migraine Drugs Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Sumatriptan
Figure 12. Product Picture of Zolmitriptan
Figure 13. Product Picture of Rizatriptan
Figure 14. Product Picture of Others Drug
Figure 15. Global Migraine Drugs Sales Market Share byType in 2025
Figure 16. Global Migraine Drugs Revenue Market Share byType (2020-2025)
Figure 17. Migraine Drugs Consumed in Hospitals
Figure 18. Global Migraine Drugs Market: Hospitals (2020-2025) & (K Pcs)
Figure 19. Migraine Drugs Consumed in Clinics
Figure 20. Global Migraine Drugs Market: Clinics (2020-2025) & (K Pcs)
Figure 21. Migraine Drugs Consumed in Household Use
Figure 22. Global Migraine Drugs Market: Household Use (2020-2025) & (K Pcs)
Figure 23. Migraine Drugs Consumed in Others
Figure 24. Global Migraine Drugs Market: Others (2020-2025) & (K Pcs)
Figure 25. Global Migraine Drugs Sale Market Share by Application (2024)
Figure 26. Global Migraine Drugs Revenue Market Share by Application in 2025
Figure 27. Migraine Drugs Sales by Company in 2025 (K Pcs)
Figure 28. Global Migraine Drugs Sales Market Share by Company in 2025
Figure 29. Migraine Drugs Revenue by Company in 2025 ($ millions)
Figure 30. Global Migraine Drugs Revenue Market Share by Company in 2025
Figure 31. Global Migraine Drugs Sales Market Share by Geographic Region (2020-2025)
Figure 32. Global Migraine Drugs Revenue Market Share by Geographic Region in 2025
Figure 33. Americas Migraine Drugs Sales 2020-2025 (K Pcs)
Figure 34. Americas Migraine Drugs Revenue 2020-2025 ($ millions)
Figure 35. APAC Migraine Drugs Sales 2020-2025 (K Pcs)
Figure 36. APAC Migraine Drugs Revenue 2020-2025 ($ millions)
Figure 37. Europe Migraine Drugs Sales 2020-2025 (K Pcs)
Figure 38. Europe Migraine Drugs Revenue 2020-2025 ($ millions)
Figure 39. Middle East & Africa Migraine Drugs Sales 2020-2025 (K Pcs)
Figure 40. Middle East & Africa Migraine Drugs Revenue 2020-2025 ($ millions)
Figure 41. Americas Migraine Drugs Sales Market Share by Country in 2025
Figure 42. Americas Migraine Drugs Revenue Market Share by Country (2020-2025)
Figure 43. Americas Migraine Drugs Sales Market Share byType (2020-2025)
Figure 44. Americas Migraine Drugs Sales Market Share by Application (2020-2025)
Figure 45. United States Migraine Drugs Revenue Growth 2020-2025 ($ millions)
Figure 46. Canada Migraine Drugs Revenue Growth 2020-2025 ($ millions)
Figure 47. Mexico Migraine Drugs Revenue Growth 2020-2025 ($ millions)
Figure 48. Brazil Migraine Drugs Revenue Growth 2020-2025 ($ millions)
Figure 49. APAC Migraine Drugs Sales Market Share by Region in 2025
Figure 50. APAC Migraine Drugs Revenue Market Share by Region (2020-2025)
Figure 51. APAC Migraine Drugs Sales Market Share byType (2020-2025)
Figure 52. APAC Migraine Drugs Sales Market Share by Application (2020-2025)
Figure 53. China Migraine Drugs Revenue Growth 2020-2025 ($ millions)
Figure 54. Japan Migraine Drugs Revenue Growth 2020-2025 ($ millions)
Figure 55. South Korea Migraine Drugs Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast Asia Migraine Drugs Revenue Growth 2020-2025 ($ millions)
Figure 57. India Migraine Drugs Revenue Growth 2020-2025 ($ millions)
Figure 58. Australia Migraine Drugs Revenue Growth 2020-2025 ($ millions)
Figure 59. ChinaTaiwan Migraine Drugs Revenue Growth 2020-2025 ($ millions)
Figure 60. Europe Migraine Drugs Sales Market Share by Country in 2025
Figure 61. Europe Migraine Drugs Revenue Market Share by Country (2020-2025)
Figure 62. Europe Migraine Drugs Sales Market Share byType (2020-2025)
Figure 63. Europe Migraine Drugs Sales Market Share by Application (2020-2025)
Figure 64. Germany Migraine Drugs Revenue Growth 2020-2025 ($ millions)
Figure 65.France Migraine Drugs Revenue Growth 2020-2025 ($ millions)
Figure 66. UK Migraine Drugs Revenue Growth 2020-2025 ($ millions)
Figure 67. Italy Migraine Drugs Revenue Growth 2020-2025 ($ millions)
Figure 68. Russia Migraine Drugs Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & Africa Migraine Drugs Sales Market Share by Country (2020-2025)
Figure 70. Middle East & Africa Migraine Drugs Sales Market Share byType (2020-2025)
Figure 71. Middle East & Africa Migraine Drugs Sales Market Share by Application (2020-2025)
Figure 72. Egypt Migraine Drugs Revenue Growth 2020-2025 ($ millions)
Figure 73. South Africa Migraine Drugs Revenue Growth 2020-2025 ($ millions)
Figure 74. Israel Migraine Drugs Revenue Growth 2020-2025 ($ millions)
Figure 75.Turkey Migraine Drugs Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC Countries Migraine Drugs Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Migraine Drugs in 2025
Figure 78. Manufacturing Process Analysis of Migraine Drugs
Figure 79. Industry Chain Structure of Migraine Drugs
Figure 80. Channels of Distribution
Figure 81. Global Migraine Drugs Sales MarketForecast by Region (2026-2031)
Figure 82. Global Migraine Drugs Revenue Market ShareForecast by Region (2026-2031)
Figure 83. Global Migraine Drugs Sales Market ShareForecast byType (2026-2031)
Figure 84. Global Migraine Drugs Revenue Market ShareForecast byType (2026-2031)
Figure 85. Global Migraine Drugs Sales Market ShareForecast by Application (2026-2031)
Figure 86. Global Migraine Drugs Revenue Market ShareForecast by Application (2026-2031)
More Publications
Global Pertussis Treatment Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
95 pages
Global Cardiovascular Interventional Devices Market Growth 2025-2031
US$ 3,660.00
May 2025
134 pages
Global Amplifying Stethoscopes Market Growth 2023-2029
US$ 3,660.00
February 2023
94 pages
Global Alexipharmic Drugs Market Growth 2025-2031
US$ 3,660.00
October 2025
96 pages
